| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 61 | Method of manufacturing an aqueous solution of an alkali metal salt of methionine | JP28612486 | 1986-12-02 | JPH078852B2 | 1995-02-01 | クロード・ジロニエ; ルネ・モワソン |
| 62 | JPH0588219B2 - | JP16500985 | 1985-07-25 | JPH0588219B2 | 1993-12-21 | JIIKUFURIITO ROOZENBERUGAA; UERUNAA SUTETSUGUMAN |
| 63 | JPH0377839B2 - | JP10577083 | 1983-06-15 | JPH0377839B2 | 1991-12-11 | MURAKAMI MITSUHIRO; MIKAMI TAKUHIRO; SUZUKI AKITO |
| 64 | JPH0375540B2 - | JP33683687 | 1987-12-28 | JPH0375540B2 | 1991-12-02 | ANDORE RANTSU |
| 65 | Diaryl-acetylene | JP20830790 | 1990-08-08 | JPH0377863A | 1991-04-03 | BERUNTO YANSEN; HANSUUHAINAA BUYUSUTO |
| NEW MATERIAL: A compound of formula I [R 1 is H or 1-4C alkyl; R 2 and R 3 are each H, or when R 1 is H, then R 2 and R 3 together form formula II (B is CH 2CH 2), formula III (Z is 1-2C alkyl), etc.; R 4 is 1-6C alkyl; (n) is 0-2]. EXAMPLE: 2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-(4-methylsulfonyl- phenyl)-acetylene. USE: Therapeutic agents for skin diseases. Also useful for local or systemic prevention or treatment of pre-cancer or cancer of the skin, mucous membrane or internal organs, and useful for treatment of rheumatic diseases. PROCESS: A compound of formula I can be prepared by halogenation of a stilbene of formula II, followed by removal of two mol hydrogen halide. The reaction is carried out effectively with bromine in a solvent at 50°C, preferably -15-0°C. COPYRIGHT: (C)1991,JPO | ||||||
| 66 | Improved esterification of thiopropionate | JP5140488 | 1988-03-04 | JPS63243070A | 1988-10-07 | KAAKUUTSUDO SUTORAA KOTSUTOMAN; JIYOSEFU ANDORIYUU KUKUTSUKOUS |
| 67 | Manufacture of mercaptomethylphenol | JP32817287 | 1987-12-24 | JPS63185954A | 1988-08-01 | BUERUNAA SUTEEKUMAN; HANSU RUDORUFU MAIYAA; SAMUERU EBUANSU; ROJIYAA MARUTEIN; RETO RUISOORI |
| 68 | Synthesis of 2-pereluoroalkylethane thiol | JP33683687 | 1987-12-28 | JPS63174966A | 1988-07-19 | ANDORE RANTSU |
| 69 | Method of reducing organic sulfur compound | JP21928887 | 1987-09-03 | JPS6379869A | 1988-04-09 | TOONI DOTSUKUNAA; MANFUREETO ZAUERUWARUTO |
| 70 | JPS62502551A - | JP50253186 | 1986-04-23 | JPS62502551A | 1987-10-01 | |
| 71 | Manufacture of phenolic thiocarboxylic acid ester | JP16500985 | 1985-07-25 | JPS6143158A | 1986-03-01 | JIIKUFURIITO ROOZENBERUGAA; BUERUNAA SUTETSUGUMAN |
| 72 | Novel carnitine derivative, manufacture and remedy for burn, epythelial disease and respiratory disease | JP5475282 | 1982-03-31 | JPS57176949A | 1982-10-30 | MARIA ORUNERA CHINCHI; EMUMA KARESHIMA; KARURO BAGORIINI; PAORO DE BITSUTO |
| 73 | TOUGH, REPROCESSABLE ELASTOMERS AND METHODS OF MAKING AND USING SAME | PCT/GB2021052921 | 2021-11-11 | WO2022101632A1 | 2022-05-19 | BECKER MATTHEW L; DOVE ANDREW P; STUBBS CONNOR; WORCH JOSH; PRYDDERCH HANNAH |
| The present disclosure describes, in part, a polymer, for example a thermoplastic polyurethane elastomer, comprising one or more subunits comprising (i) at least one dianhydrohexitole moiety (ii) at least one urethane moiety and (ill) a thiol moiety having two or more sulphur atoms. The thermoplastic polyurethane elastomers may be biodegradable and possess excellent thermoplastic properties, including outstanding toughness, resulting from its semi-crystallinity and low glass transition temperature, that surpasses many leading plastics such as nylon 6 and high-density polyethylene (HOPE) and methods of making same. | ||||||
| 74 | PROCESSES FOR THE PREPARATION OF ALPHA-HYDROXY ESTERS BY ESTERIFICATION OF ALPHA-HYDROXY ACIDS | PCT/US2020/049222 | 2020-09-03 | WO2021046234A1 | 2021-03-11 | HUANG, Shengshu; LI, Fangyi; XU, Li; NUYENS, Filip; LAO, Ye; SALAKLANG, Jatuporn; TANG, Zhuo |
The present disclosure provides processes for preparing an alpha-hydroxy ester from the corresponding alpha-hydroxy acid by transesterification. Also provided are alphahydroxy esters prepared according to processes disclosed herein and compositions comprising the alpha-hydroxy esters. |
||||||
| 75 | PROCESS FOR PRODUCING METHYL MERCAPTAN FROM DIMETHYL SULFIDE | PCT/US2017/034391 | 2017-05-25 | WO2017210070A1 | 2017-12-07 | PICHAI, Puvin; ROLSTON, James; SCHUBERT, Stephan; MLECZKO, Leslaw; ASSMANN, Jens; GROSS-HARDT, Edwin; AJMERA, Pankaj |
The present invention generally relates to the manufacture of methyl mercaptan using recycled dimethyl sulfide. In particular, the invention relates to a process for the continuous production of methyl mercaptan via the catalytic conversion of dimethyl sulfide using a non-promoted Al2O3 catalyst at low temperatures. |
||||||
| 76 | FUNCTIONALIZED POLYMER COMPOSITIONS | PCT/US2013/025351 | 2013-02-08 | WO2013119955A1 | 2013-08-15 | ARHANCET, Graciela B.; MAHONEY, Matthew; WANG, Xiaojun; KARNATI, Rangarani |
Functionalized polymers include homopolymers and copolymers of 2-hydroxy-4-(methylthio)-butanoic acid (HMTBA) and uses in industrial applications and in agricultural applications. The homopolymers and copolymers may be, for example, used in polymer blends, used as nutritives and in feed compositions, and used in combination with a pharmaceutical or nutritive. The homopolymers and copolymers provided herein have advantageous physical properties which can, in some instances, provide a pH switch effect. The homopolymers and copolymers may be used in a variety of contexts including, in polymer blends, in animal feed, and in combination with a pharmaceutical agent. |
||||||
| 77 | ESTER COMPOUND AND USE THEREOF | PCT/JP2011/054226 | 2011-02-18 | WO2011105526A1 | 2011-09-01 | MATSUO, Noritada |
An ester compound represented by formula (1): wherein R1 represents 2-propenyl or 2-propynyl, and R2 represents C1-C4 alkyl, has an excellent pest control effect and is therefore useful as an active ingredient of a pest control agent. |
||||||
| 78 | PROTEIN KINASE C INHIBITOR, RELATED COMPOSITION, AND METHOD OF USE | PCT/US2004005855 | 2004-02-26 | WO2004078118A3 | 2006-03-02 | WANG SHAOMENG; BLUMBERG PETER M; LEWIN NANCY |
| Compounds of the formula (1), (2), (3), (4), (5) or (6) or a pharmaceutically acceptable salt thereof, wherein A is a DAG receptor-binding moiety, L is a linker moiety, and B is a zinc finger reactive moiety, and, a pharmaceutical composition comprising an above compound, and methods of use. | ||||||
| 79 | TWO-PHOTON OR HIGHER-ORDER ABSORBING OPTICAL MATERIALS | PCT/US1999/008383 | 1999-04-16 | WO99053242A1 | 1999-10-21 | |
| Disclosed are highly efficient multiphoton absorbing compounds and methods of their use. The compounds generally include a bridge of pi-conjugated bonds connecting electron donating groups or electron accepting groups. The bridge may be substituted with a variety of substituents as well. Solubility, lipophilicity, absorption maxima and other characteristics of the compounds may be tailored by changing the electron donating groups or electron accepting groups, the substituents attached to or the length of the pi-conjugated bridge. Numerous photophysical and photochemical methods are enabled by converting these compounds to electronically excited states upon simultaneous absorption of at least two photons of radiation. The compounds have large two-photon or higher-order absorptivities such that upon absorption, one or more Lewis acidic species, Lewis basic species, radical species or ionic species are formed. | ||||||
| 80 | SYNTHESIS OF ETP DERIVATIVES | PCT/US2018/033967 | 2018-05-22 | WO2018217811A1 | 2018-11-29 | HORNE, David; XIE, Jun |
Provided herein, inter alia, is the synthesis of ETP derivatives. The synthesis methods described herein include converting a ring bridging trisulfide compound to a ring bridging disulfide compound. Also provided herein are compositions, which include ring bridging trisulfide compounds and ring bridging disulfide compounds. |
||||||
